Drug Product
Company Overview
About
Natech Plastics is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Formulation Development, Process Development, Scale-up
Therapeutic Areas
Immunology
Rheumatology
Quick Facts
HQ:United States
Founded:1995
Employees:2,470
Capabilities & Services
Core Capabilities
- Peptide Synthesis
- Small Molecule API
- Formulation Development
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Inhalation
Containment Capabilities
OEB 5 (≤1 µg/m³)
Cytotoxic / ADC Handling
Production Scales
Pilot Scale
Phase I Clinical Trials
Clinical
Markets Served
Asia-Pacific
Regulatory Approvals
Drug Approval LKAWKD
FDA · #APR-9H2O5W0Z · 2018-06-01
Drug Approval SB086R
EMA · #APR-WIYQ2YS2 · 2021-04-01
Certifications
EMA GMP Certificate
European Medicines Agency
Cert #: CERT-9KG47M5J
Issued: 2020-03-03
Expires: 2025-02-28
MHRA GMP
UK Medicines and Healthcare products Regulatory Agency
Cert #: CERT-QXA6P3XR
Issued: 2020-07-18
Expires: 2025-03-10
Health Canada GMP
Health Canada
Cert #: CERT-PM2QBI3X
Issued: 2020-09-17
Expires: 2025-07-11
Loading CDMO intelligence...
Key facts about Natech Plastics
- Natech Plastics is headquartered in the United States.
- Natech Plastics was founded in 1995.
- Natech Plastics has 2,470 employees.
- Natech Plastics's capabilities include Peptide Synthesis, Small Molecule API and Formulation Development.
Find CDMOs like Natech Plastics
Directory pages this company appears in, each with the full list of matching manufacturers.